A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy
帕利法明（重组人角质形成细胞生长因子）治疗接受抗逆转录病毒治疗的 HIV-1 感染患者 CD4+ T 淋巴细胞恢复不足的随机对照试验
期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:2.9
doi:10.1097/QAI.0000000000000195
Jeffrey M Jacobson, Hongying Wang, Rebeka Bordi, Lu Zheng, Barry H Gross, Alan L Landay, John Spritzler, Jean-Pierre Routy, Constance Benson, Judith Aberg, Pablo Tebas, David W Haas, Jennifer Tiu, Kristine Coughlin, Lynette Purdue, Rafick-Pierre Sekaly; AIDS Clinical Trials Group (ACTG) A5212 Protoc
